Blackbird Labs
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $100M
Overview
A biotech targeting metabolic pathways to treat age-related and degenerative diseases.
MetabolicRegenerative MedicineAging
Technology Platform
A platform focused on modulating core metabolic and nutrient-sensing pathways to induce tissue repair and combat age-related degeneration.
Funding History
1Total raised:$100M
Venture$100M
Opportunities
Potential to pioneer a new class of therapeutics for the enormous and growing burden of age-related chronic diseases.
Risk Factors
Extremely high scientific risk; translating fundamental aging biology into safe, effective drugs is an unproven and long-term endeavor.
Competitive Landscape
Operates in the innovative but speculative longevity and metabolic health space, competing with other early-stage biotechs targeting aging mechanisms.